New Drug Advances The Fight Against Pancreatic Cancer

A new drug combination can help patients with pancreatic cancer live months longer than on standard therapy.

Sections:  living   
Topics:  cancer   drugs   health   medical   pancreatic cancer   
RELATED ARTICLES
  • Most people aren't meeting exercise guidelines
    Most adults in the USA aren't meeting the federal physical activity recommendations for both aerobic exercise and muscle-strengthening activity, according to government statistics out today. About 79% of adults don't meet the physical activity guidelines that advise getting at least 2½ hours a week of moderate-intensity aerobic activity such as brisk walking, or one hour and 15 minutes a week of vigorous-intensity aerobic activity, such as jogging. More
  • US suicide rate rose sharply among middle-aged
    Health officials say suicides among middle-aged Americans climbed at a startling rate over the past decade, a period that included the recession. Overall, the suicide rate for the age group jumped 28 percent from 1999 to 2010. And among whites, it shot up 40 percent.... More
  • Cost of feeding a family of four: $146 to $289 a week
    Latest statistics give a range of prices for feeding a family of four a healthy diet. The cost of feeding a family of four a healthy diet can run $146 to $289 a week, according to the latest numbers from the U.S. More
  • 2-year-old girl gets windpipe made from stem cells
    A 2-year-old girl born without a windpipe now has a new one grown from her own stem cells, the youngest patient in the world to benefit from the experimental treatment.... More
  • Study: New bird flu jumped directly from chickens
    Chinese scientists have for the first time found strong evidence of how humans got infected with a new strain of bird flu: from chickens at a live market. In a small study of four patients who caught the new H7N9 virus, Chinese scientists compared swabs from birds at live markets in eastern China to virus samples from patients. More
BING NEWS:
  • EGFR Inhibitor Market to Accelerate Substantially During the Study Period (2020–2034) | DelveInsight
    According to DelveInsight’s analysis, the growth of the EGFR inhibitor market is expected to be mainly driven by increasing incidence, a rise in awareness and access to treatment, and robust pipeline ...
    04/22/2024 - 6:00 am | View Link
  • Indaptus Therapeutics Presents Positive Mechanism of Action Data at the American Association for Cancer Research Annual Meeting
    Results Indicate Decoy Platform Broadly Boosts Immune System's Ability to Fight Tumors Directly and IndirectlyNEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- , Inc, (Nasdaq: INDP), a clinical stage ...
    04/11/2024 - 12:30 am | View Link
  • W. MI man first in world to test pancreatic cancer imaging agent
    A West Michigan man with pancreatic cancer was the first person in the world to test a new imaging agent, BAMF Health says.
    04/10/2024 - 9:10 am | View Link
  • AACR News: Pancreatic Cancer Outcomes May Improve with Presurgical Nivolumab/Chemo Combo
    Immunotherapy, in combination with chemotherapy, before surgery may improve long-term outcomes for some people with pancreatic cancer.
    04/7/2024 - 4:30 am | View Link
  • Cancer experts demand action to end ongoing drug shortage: ‘People’s lives are really at stake’
    He said the shortage means some cancer patients are not able to access medications that have been maintaining their fight against the ... how over the years, advances in cancer therapeutics ...
    02/23/2024 - 11:18 am | View Link
  • More

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Living News